ANGIOTENSIN-II, SODIUM, AND CARDIOVASCULAR HYPERTROPHY IN SPONTANEOUSLY HYPERTENSIVE RATS

被引:42
作者
HARRAP, SB
MITCHELL, GA
CASLEY, DJ
MIRAKIAN, C
DOYLE, AE
机构
[1] Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg
关键词
SALT; ANGIOTENSIN-II; BLOOD PRESSURE; HYPERTROPHY; ANGIOTENSIN CONVERTING ENZYME INHIBITORS; RATS; INBRED SHR;
D O I
10.1161/01.HYP.21.1.50
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin II (Ang II) may cause cardiovascular hypertrophy as a consequence of increased blood pressure or possibly by direct trophic actions. To dissociate Ang II and blood pressure in young spontaneously hypertensive rats (SHR), we used sodium loading during angiotensin converting enzyme inhibitor treatment. Animals were treated between 6 and 10 weeks of age with perindopril to lower Ang II and blood pressure, or with perindopril and 1% saline drinking fluid or perindopril and aldosterone infusion to lower Ang II but maintain high blood pressure. Blood pressure, heart weight, and media/lumen ratio of mesenteric resistance arteries were studied while rats were on treatment at 10 weeks of age and 15 weeks after treatment at 25 weeks of age. Perindopril lowered blood pressure and inhibited the development of cardiovascular hypertrophy. Saline or aldosterone restored high blood pressure during perindopril treatment and resulted in increased heart weight/body weight and resistance artery media/lumen ratios in direct proportion to the elevation of blood pressure. Because increased structure occurred despite perindopril treatment, we conclude that direct trophic actions of Ang II are not essential for the development of cardiovascular hypertrophy in young SHR and that the antitrophic actions of angiotensin converting enzyme inhibitors depend more on changes in blood pressure than on Ang II. However, restoration of blood pressure and structure by sodium during perindopril treatment raises the possibility that the design of the cardiovascular system and blood pressure may depend indirectly on Ang II through effects on sodium metabolism.
引用
收藏
页码:50 / 55
页数:6
相关论文
共 21 条
[1]   DIFFERENTIAL DEVELOPMENT OF VASCULAR AND CARDIAC-HYPERTROPHY IN GENETIC-HYPERTENSION - RELATION TO SYMPATHETIC FUNCTION [J].
ADAMS, MA ;
BOBIK, A ;
KORNER, PI .
HYPERTENSION, 1989, 14 (02) :191-202
[2]   DIFFERENTIAL REGULATION OF ANGIOTENSIN PEPTIDE LEVELS IN PLASMA AND KIDNEY OF THE RAT [J].
CAMPBELL, DJ ;
LAWRENCE, AC ;
TOWRIE, A ;
KLADIS, A ;
VALENTIJN, AJ .
HYPERTENSION, 1991, 18 (06) :763-773
[3]   SALT BLOCKS THE RENAL BENEFITS OF RAMIPRIL IN DIABETIC HYPERTENSIVE RATS [J].
FABRIS, B ;
JACKSON, B ;
JOHNSTON, CI .
HYPERTENSION, 1991, 17 (04) :497-503
[4]   THE RELATION OF CELL-VOLUME, CELL SODIUM AND THE TRANSMEMBRANE SODIUM-GRADIENT TO BLOOD-PRESSURE [J].
FRIEDMAN, SM .
JOURNAL OF HYPERTENSION, 1990, 8 (01) :67-73
[5]  
HARRAP SB, 1986, J HYPERTENS, V4, pS249
[6]   EFFECTS OF SODIUM-INTAKE AND ALDOSTERONE ON THE RENAL PRESSURE-NATRIURESIS [J].
HARRAP, SB ;
CLARK, SA ;
FRASER, R ;
TOWRIE, A ;
BROWN, AJ ;
LEVER, AF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1988, 254 (05) :F697-F703
[7]   PERSISTENT EFFECTS ON BLOOD-PRESSURE AND RENAL HEMODYNAMICS FOLLOWING CHRONIC ANGIOTENSIN CONVERTING ENZYME-INHIBITION WITH PERINDOPRIL [J].
HARRAP, SB ;
NICOLACI, JA ;
DOYLE, AE .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1986, 13 (11-12) :753-765
[8]   BRIEF ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR TREATMENT IN YOUNG SPONTANEOUSLY HYPERTENSIVE RATS REDUCES BLOOD-PRESSURE LONG-TERM [J].
HARRAP, SB ;
VANDERMERWE, WM ;
GRIFFIN, SA ;
MACPHERSON, F ;
LEVER, AF .
HYPERTENSION, 1990, 16 (06) :603-614
[9]   A DEVELOPMENTAL GENETIC MECHANISM INVOLVING ANGIOTENSIN IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
HARRAP, SB .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1992, :19-22
[10]  
HARRAP SB, 1989, CURRENT ADV ACE INHI, P69